Lv3
230 积分 2024-07-10 加入
A Phase II Clinical Trial of E7820 for Patients with Relapsed/Refractory Myeloid Malignancies with Mutations in Splicing Factor Genes
12天前
已完结
Antibody–Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond
17天前
已完结
The immunology of asthma and chronic rhinosinusitis
1个月前
已完结
The immunology of asthma
1个月前
已完结
Anti-cytokine biologics for asthma in adults
4个月前
已完结
Efficacy of osimertinib resumption with dabrafenib and trametinib for elderly patients with EGFR-mutated lung adenocarcinoma harboring acquired BRAF V600E resistant mutation resistant to osimertinib
8个月前
已完结
Seventeen on inflammation
9个月前
已完结
Ustekinumab versus vedolizumab and ustekinumab versus tumor necrosis factor alpha agent infectious adverse effects in patients with ulcerative colitis, a real-world data study
9个月前
已完结
Ruxolitinib Alleviates Inflammation and Fortifies Skin Barrier Function Through Dampening IL‐13
9个月前
已完结
POS1135 Discovery and Characterization of Novel Oral TNF-Alpha Inhibitors as Potential Treatments for Autoimmune Diseases
11个月前
已关闭
皖公网安备34019202002308
